Information on the current situation, as of 28 November 2023
Vaccinated people, Switzerland and Liechtenstein, 21.12.2020 to 03.07.2023
Several vaccines for preventing COVID-19 are authorised in Switzerland and Liechtenstein. A booster vaccination with an mRNA vaccine from Moderna (Spikevax®) or Pfizer/BioNTech (Comirnaty®) and the Novavax (Nuvaxovid®) vaccine is recommended at the earliest four months after the last vaccine or after infection for everyone aged 16 or older. More information on the recommended vaccines and the time period between vaccines can be found on the FOPH website > Coronavirus: vaccination.
Information on adverse vaccination reactions (AVRs) is collected via Swissmedic’s spontaneous reporting system. Swissmedic reviews and evaluates the reported side effects. More details can be found on the Swissmedic website. The time frame desired can be selected with the slider below the graph.
The Federal Office of Public Health (FOPH) has decided to suspend the requirement to report COVID-19 vaccinations with effect from 1 July 2023. The data on the Covid-19 dashboard will therefore no longer be updated.
Distribution by age group
Switzerland and Liechtenstein